Syfovre (pegcetacoplan) is a prescription drug used to treat an eye condition called geographic atrophy. Your cost may depend on your treatment plan, your insurance coverage (if you have it), and how ...
Moby Strategic Pillars and Performance Drivers. Management characterizes 2025 as a foundational year of disciplined e ...
On Tuesday, JP Morgan highlighted its survey related to Apellis Pharmaceuticals, Inc.’s (NASDAQ:APLS) Syfovre and Astellas Pharma Inc’s (OTC:ALPMF) (OTC:ALPMY) Izervay. On average, surveyed physicians ...
Despite witnessing modest growth in demand over the past three months, Apellis Pharmaceuticals’ complement inhibitor for geographic atrophy (GA), Syfovre, may have hit a performance “nadir” in 2024’s ...
Get ready to see more of Henry Winkler on TV talking about geographic atrophy (GA). During a quarterly conference call, as Apellis Pharmaceuticals discussed its plan to increase sales of GA treatment ...
Thank you, Eva, and thank you all for joining us this morning. Before turning to our fourth quarter results, I would like to ...
Apellis Pharmaceuticals' Syfovre, despite initial safety concerns, shows strong revenue growth and is nearing profitability, making it a high-risk, high-reward investment. Syfovre's adjusted safety ...
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® ...
Apellis Pharmaceuticals Inc (NASDAQ:APLS) reported a second quarter (Q2) EPS loss of $1.02, beating the consensus of -$1.35. Sales came in at $95 million, up from $16.3 million a year ago, beating the ...
Please provide your email address to receive an email when new articles are posted on . Six cases of intraocular inflammation and retinal vasculitis have been reported. Retina specialists should ...
WALTHAM, Mass., June 10, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (APLS) today announced that SYFOVRE ® (pegcetacoplan injection) preserved visual function at 36 months in patients with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Apellis is exclusively distributing injection kits with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results